How another firm's FDA approval could mean a big win for Denali Therapeutics
Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...
Winners and wishers: 8 potential Bay Area drug approvals coming this year
Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
Generation Bio is a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases. The company is developing redosable therapeutics that reprogram T ...
Fierce Biotech1d
After Eric Green's exit, new leader of NIH's genome research institute put on administrative leave: Stat
Vence Bonham Jr., the highest ranking official at the National Human Genome Research Institute (NHGRI), has been put on ...